Cargando…
Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents
Ebola hemorrhagic fever (EHF) epidemic currently ongoing in West Africa is not the first among numerous epidemics in the continent. Yet it seems to be the worst EHF epidemic outbreak caused by Ebola virus Zaire since 1976 as regards its extremely large scale and rapid spread in the population. Exper...
Autores principales: | Kiselev, O. I., Vasin, A. V., Shevyryova, M. P., Deeva, E. G., Sivak, K. V., Egorov, V. V., Tsvetkov, V. B., Egorov, A. Yu., Romanovskaya-Romanko, E. A., Stepanova, L. A., Komissarov, A. B., Tsybalova, L. M., Ignatjev, G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089462/ https://www.ncbi.nlm.nih.gov/pubmed/32214474 http://dx.doi.org/10.1134/S002689331504007X |
Ejemplares similares
-
Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter
por: Sergeeva, M. V., et al.
Publicado: (2022) -
Influenza B: Prospects for the Development of Cross-Protective Vaccines
por: Tsybalova, Liudmila M., et al.
Publicado: (2022) -
The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure
por: Vasin, A. V., et al.
Publicado: (2016) -
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice
por: Pulkina, Anastasia, et al.
Publicado: (2023) -
Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein
por: Kotlyarov, R.Y., et al.
Publicado: (2010)